Daniel Ryan Hart insider trades: Avid Bioservices (CDMO) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Daniel reports to the SEC
Open-market buys and sales
21 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Dec 26, 2024 | CDMO | ↓ Sell | 22,813 | $12.22 | $279K | Direct | Dec 27, 2024 (1d) |
| Apr 30, 2024 | CDMO | ↓ Sell | 2,826 | $7.40 | $21K | Direct | May 2, 2024 (2d) |
| Jan 10, 2024 | CDMO | ↓ Sell | 2,408 | $6.17 | $15K | Direct | Jan 11, 2024 (1d) |
| Oct 10, 2023 | CDMO | ↓ Sell | 2,040 | $9.20 | $19K | Direct | Oct 11, 2023 (1d) |
| Jul 11, 2023 | CDMO | ↓ Sell | 3,763 | $13.86 | $52K | Direct | Jul 12, 2023 (1d) |
| Jul 10, 2023 | CDMO | ↓ Sell | 1,269 | $13.77 | $17K | Direct | Jul 11, 2023 (1d) |
| Jun 29, 2023 | CDMO | ↓ Sell | 6,884 | $12.70 | $87K | Direct | Jun 30, 2023 (1d) |
| Apr 10, 2023 | CDMO | ↓ Sell | 1,280 | $19.80 | $25K | Direct | Apr 11, 2023 (1d) |
| Apr 5, 2023 | CDMO | ↓ Sell | 1,250 | $19.00 | $24K | Direct | Apr 7, 2023 (2d) |
| Mar 14, 2023 | CDMO | ↓ Sell | 5,000 | $19.00 | $95K | Direct | Mar 16, 2023 (2d) |
| Jan 10, 2023 | CDMO | ↓ Sell | 1,499 | $14.44 | $22K | Direct | Jan 11, 2023 (1d) |
| Oct 10, 2022 | CDMO | ↓ Sell | 1,262 | $17.90 | $23K | Direct | Oct 11, 2022 (1d) |
| Jul 11, 2022 | CDMO | ↓ Sell | 4,324 | $17.75 | $77K | Direct | Jul 12, 2022 (1d) |
| Jul 8, 2022 | CDMO | ↓ Sell | 4,150 | $17.53 | $73K | Direct | Jul 11, 2022 (3d) |
| Apr 11, 2022 | CDMO | ↓ Sell | 726 | $18.56 | $13K | Direct | Apr 12, 2022 (1d) |
| Jan 10, 2022 | CDMO | ↓ Sell | 877 | $21.58 | $19K | Direct | Jan 11, 2022 (1d) |
| Jan 3, 2022 | CDMO | ↓ Sell | 500 | $29.07 | $15K | Direct | Jan 5, 2022 (2d) |
| Oct 11, 2021 | CDMO | ↓ Sell | 760 | $22.37 | $17K | Direct | Oct 12, 2021 (1d) |
| Jul 12, 2021 | CDMO | ↓ Sell | 5,409 | $25.61 | $139K | Direct | Jul 13, 2021 (1d) |
| Jul 13, 2020 | CDMO | ↓ Sell | 2,056 | $6.88 | $14K | Direct | Jul 14, 2020 (1d) |
| Mar 16, 2020 | CDMO | ↑ Buy | 7,500 | $3.77 | $28K | Direct | Mar 17, 2020 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Daniel Ryan Hart's insider trades
Daniel Ryan Hart is Chief Financial Officer at Avid Bioservices (CDMO). Since Mar 16, 2020, Daniel has reported 1 open-market purchase worth $28K and 20 sales worth $1.0M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include option exercises (21 filings), other transactions (12 filings), shares returned to the company (6 filings), grants and awards (6 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CDMO insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.